Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple-negative breast cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of PD-1 inhibitors or PD-L1 inhibitors plus chemotherapy compared with chemotherapy for people with early triple-negative breast cancer.

This is a protocol.